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Introduction {#sec1}
============

Embryonic hematopoiesis occurs in three successive waves characterized by a transient primitive wave that is primarily erythroid and myeloid in lineage, an intermediate wave that generates erythromyeloid progenitors, and the definitive wave arising from hematopoietic stem cells (HSCs) that are capable of self-renewal and differentiation into various hematopoietic lineages ([@bib29], [@bib31]). In mammals, HSCs arise from the aorta-gonad-mesonephros (AGM) and migrate to fetal liver, thence bone marrow (BM), where lifelong hematopoiesis takes place. In zebrafish, HSCs in definitive hematopoiesis arise from the hemogenic endothelium lining the ventral wall of the dorsal aorta (VDA) via endothelial-to-hematopoietic transition (EHT) ([@bib32]). HSCs migrate into the cardinal vein and are carried to the caudal hematopoietic tissue (CHT) where they expand and subsequently colonize the kidney marrow, the equivalent of mammalian BM.

The Notch pathway plays essential roles at different stages of hematopoietic development. During early embryognesis, somitic expression of Notch ligands, induced by non-canonical Wnt ligand and fibroblast growth factor, has been shown to play a pivotal role in hematopoietic specification ([@bib3]). Direct interaction between the somite and migratory posteral lateral plate mesoderm induced hemogenic endothelial programming of the latter. Subsequently, proinflammatory signals from primitive neutrophils induced expression of Notch ligands in the endothelial cells conducive to the development of HSCs ([@bib3], [@bib33]). In embryonic tissues, maturation of the Notch receptor occurs via a series of proteolytic cleavages. The first cleavage occurs in the Golgi complex where the nascent receptor is glycosylated and cleaved by furin-like convertases to a Notch receptor precursor. The latter comprises an N-terminal extracellular and a C-terminal intracellular domain and is transported to cell surface. Once bound and activated, the ligand-bound Notch extracellular domain is cleaved by the ADAM family metalloproteases and endocytosed by adjacent signal-sending cells. The rest of the receptor is cleaved by γ-secretase to release Notch intracellular domain (NICD). NICD translocates into the nucleus where it associates with DNA binding protein CSL (CBF1/Su(H)/Lag-1)/RBPjκ to activate transcription of target genes, including *Hes1*, *Hes5*, *Hey2*, and *Gata2* ([@bib3], [@bib8], [@bib10]). *gata2b* activation is more restricted to the hemogenic endothelium and accounts for HSC development, whereas *gata2a* activation occurs more widely in the vascular system ([@bib2]).

ADP-ribosylation factor-like protein 4A (ARL4A) is a member of the ADP-ribosylation factor (ARF) family ([@bib6], [@bib7], [@bib25]). The family comprises 6 ARF (ARF1-6) and over 20 ARL proteins. They are low-molecular-weight guanine-nucleotide binding proteins (G proteins) that control membrane traffic and organelle structure and each member is regulated through activation by GTP binding and inactivation by GTP hydrolysis. In particular, ARL4 encompasses three isoforms (ARL4A, ARL4C, and ARL4D). ARL4A has been shown to express in the cell membrane, cytoplasm, and nuclei ([@bib9], [@bib16]) and participate in Golgi complex organization ([@bib17]), cytoskeleton remodeling ([@bib23]), and membrane protein trafficking ([@bib9]). Gene expression profiling by microarray in zebrafish has demonstrated expression of *arl4a* in hematopoietic tissues during zebrafish development ([@bib15]). However, its role in embryonic hematopoiesis is currently unclear.

In this study, we demonstrate expression of *arl4aa*, a member of the *arl4a* subfamily, in hematopoietic tissues during embryonic development and reveal a hitherto undescribed function of *arl4aa* in the initiation of definitive hematopoiesis by maintaining Golgi complex integrity and the maturation of the Notch receptor in hematopoietic stem cells. The observations provide important insights into the regulation of definitive hematopoiesis during embryonic development.

Results {#sec2}
=======

ARL4 Family Members Are Highly Conserved in Human and Zebrafish Species {#sec2.1}
-----------------------------------------------------------------------

The zebrafish Arl4 subfamily comprises five isoforms: Arl4aa, Arl4ab, Arl4ca, Arl4cb, and Arl4d. They share in common an N-terminal helix domain, and switch1, switch2, and inter-switch domains as well as a C-terminal nuclear localization signal domain ([Figure S1](#mmc1){ref-type="supplementary-material"}A). The unique short basic extension in the latter differentiates Arl4 from other family members ([@bib22]). Zebrafish Arl4aa and Arl4ab share 89.5% and 87.6% consensus amino acid sequence with human ARL4A and mouse ARL4A ([Figure S1](#mmc1){ref-type="supplementary-material"}B). Phylogenetic analysis demonstrated that zebrafish Arl4aa and Arl4ab cluster with human, mouse, and *Xenopus* Arl4a ([Figure S1](#mmc1){ref-type="supplementary-material"}C).

Zebrafish *arl4aa* Is Specifically Expressed in the AGM Region {#sec2.2}
--------------------------------------------------------------

*arl4aa* is expressed in the intermediate cell mass and tail bud at 18 h postfertilization (hpf), along the DA at 24 and 36 hpf, and in the CHT at 48 hpf. Diffuse expression is also found in the head at 24, 36, and 48 hpf ([Figures 1](#fig1){ref-type="fig"}A--1C). Histological sectioning of the trunk showed that *arl4aa* was expressed almost exclusively in the VDA ([Figures 1](#fig1){ref-type="fig"}D and 1E). In the adult, *arl4aa* is expressed in the kidney, brain, liver, heart, and muscle, and highly expressed in the testis and spleen ([Figure 1](#fig1){ref-type="fig"}F).Figure 1Expression Pattern of *arl4aa* in Zebrafish Embryos and Adults(A--C) Whole-mount *in situ* hybridization (WISH) of *arl4aa* at (A) 18 and 24 hpf, (B) 36 hpf, and (C) 48 hpf.(D and E) Cross-sections of the trunk at 24 (D) and 36 hpf (E) as shown by H&E staining (left panels) and WISH (right panels), at the level shown by the black lines in (A and B). H&E, hematoxylin and eosin; hpf, hours postfertilization; NC, notochord; DA, dorsal aorta; PCV, posterior cardinal vein. (F) Expression of *arl4aa* in different adult zebrafish tissues detected by semi-quantitative RT-PCR. Scale bars, 250 μm (A--C) and 50 μm (D and E).

Knockdown and Knockout of *arl4aa* Reduced Definitive Hematopoiesis {#sec2.3}
-------------------------------------------------------------------

Embryos at 1- to 4-cell stage were injected with *arl4aa* morpholino (MO) targeting translation start site codon. Dose-finding experiments showed that 1 ng of MO perturbed hematopoiesis with minimal effects on embryonic development and this dose was used throughout the study ([Figure S2](#mmc1){ref-type="supplementary-material"}A). Molecular targeting was confirmed by the quenching of mosaic fluorescence in *arl4aa* 5′ UTR-GFP injected embryos by *arl4aa* MO ([Figure S2](#mmc1){ref-type="supplementary-material"}B). Vasculogenesis as well as arterial or venous specification of axial vasculature were unaffected ([Figure S2](#mmc1){ref-type="supplementary-material"}C). *c-myb* expression in DA at 36 hpf and in CHT at 48 and 96 hpf ([Figures 2](#fig2){ref-type="fig"}A and 2B) was significantly reduced. Similar observations of *runx1* expression were seen ([Figures 2](#fig2){ref-type="fig"}C and 2D). *rag1* expression in the thymus at 96 hpf was also reduced ([Figure 2](#fig2){ref-type="fig"}E). Defective hematopoiesis could be rescued by MO-resistant *arl4aa* mRNA that carried 4-bp mismatch in the MO binding sequence but without amino acid changes in the coding region, proving the specificity of the hematopoietic phenotype ([Figures 2](#fig2){ref-type="fig"}A--2E). To examine the effects on EHT, a double transgenic *kdrl*:mCherry; *c-myb*:GFP fish line was used. The number of *kdrl* + *cmyb* + HSCs in the VDA per somite was significantly reduced in the morphant embryos (control embryos: 2.12 ± 0.25, n = 8; morphants: 0.40 ± 0.14, n = 8, p \< 0.001, [Figures 2](#fig2){ref-type="fig"}F and 2G).Figure 2Knockdown of Zebrafish *arl4aa* Perturbed Definitive Hematopoiesis(A) *c-myb* expression in un-injected control (top), *arl4aa* morphant (MO) (middle), and morphant rescued by *arl4aa* mRNA (bottom) at 36 (left), 48 (middle), and 96 hpf (right).(B) qRT-PCR of *c-myb* expression in control, MO, and *arl4aa* mRNA rescue groups (mRNA rescue) in embryos at 48 hpf. Data are representative of three independent experiments with error bars representing the mean ± SEM.(C) *runx1* expression at 30 hpf in un-injected control (top), *arl4aa* ( middle), and morphant rescued by *arl4aa* mRNA (bottom). Arrowheads indicate *runx1*-expressing cells in the ventral wall of the dorsal aorta (DA).(D) qRT-PCR of *runx1* expression in control, MO, and *arl4aa* mRNA rescue groups (mRNA rescue) in embryos at 30 hpf. Data are representative of three independent experiments with error bars representing the mean ± SEM.(E) *rag1* expression at 96 hpf between control (top), MO (middle), and *arl4aa* mRNA rescue groups (bottom).(F) Confocal microscope imaging of double transgenic (*cmyb*:GFP; *kdrl*:mCherry) embryos injected with *arl4aa* MO. Arrowheads denote *cmyb* + *kdrl* + HSCs along the DA. The embryos were examined at 36 hpf.(G) Number of HSCs at the floor of the DA per somite in Tg (*cmyb*:GFP; *kdrl*:mcherry) embryos at 36 hpf. The results are presented as mean ± SEM (p \< 0.001; n = 8 embryos per group in three independent experiments). Scale bars, 250 μm (A) and 100 μm (C and E).See also [Figure S2](#mmc1){ref-type="supplementary-material"}.

Zebrafish *arl4aa* Was Also Knocked Out by TALEN {#sec2.4}
------------------------------------------------

A TALEN pair that induced small insertions and deletions (Indel) at the translation start site (TALEN E2-2 pair) ([Figure 3](#fig3){ref-type="fig"}A), as well as two TALEN pairs (TE1+TE2) that induced a large gene deletion between exon 1 and 2, were designed ([Figure 3](#fig3){ref-type="fig"}B). TALEN E2-2 (60 pg each arm) showed knockout efficiency of 51% ± 5.5% ([Figure 3](#fig3){ref-type="fig"}A) and significantly reduced *c-myb* expression in CHT at 48 hpf ([Figure 3](#fig3){ref-type="fig"}C). Co-injection of TE1 + TE2 (E1 + E2 mRNA 22.5 + 30 pg per arm) resulted in a 4,611-bp deletion with knockout efficiency of 26.3% ± 2.0% ([Figure 3](#fig3){ref-type="fig"}B). To examine definitive hematopoiesis, *c-myb* expression in CHT at 48 hpf was abolished in 25% (9 out of 36) and reduced in 47% (17 out of 36) of F0 embryos ([Figure 3](#fig3){ref-type="fig"}D). Genotyping of individual embryos after evaluation of hematopoietic gene expression by whole-mount *in situ* hybridization (WISH) showed that knockout efficiency was correlated with hematopoietic phenotype, being 31% ± 2.6% and 21.6% ± 0.7% ([Figure 3](#fig3){ref-type="fig"}B), respectively, for embryos whose *c*-*myb* expression was completely absent and reduced. For both TALEN knockout models, the hematopoietic defects could be rescued by wild-type (WT) *arl4aa* mRNA ([Figures 3](#fig3){ref-type="fig"}C and 3D).Figure 3Knockout of Zebrafish *arl4aa* Perturbed Definitive HSC Development in F0 Somatic Mutants(A) Knockout of *arl4aa* by a TALEN pair (E2-2) targeting the translation start site. Upper panel: the TALEN pair; middle panel: genotyping of single embryos (numbers 1--5) injected with TALEN E2-2. Mean knockout efficiency was 51% ± 5.5% (n = 5); lower panel: DNA sequence of three mutant clones from F0 embryos.(B) Knockout of *arl4aa* by two TALEN pairs targeting exons 1 and 2 (E1 + E2). Upper panel: the TALEN pairs, primer positions indicated by red arrows. Middle panel (top): genotyping of single embryos (numbers 1--4) injected with E1 + E2, showing an amplicon of 319 bp. Middle panel (bottom): knockout efficiency was based on qPCR amplifying *arl4aa* intron 1 existing fold, which was deleted by E1 + E2. Mean knockout efficiency was 26.3% ± 2% (n = 10). Knockout efficiency was correlated with hematopoietic phenotype, being 31% ± 2.6% (n = 5) and 21.6% ± 0.7% (n = 5) for embryos whose *c-myb* expression was completely absent and reduced. Lower panel: DNA sequencing of three mutant clones from F0 embryos.(C) *c-myb* expression in control (left arm TALEN E2-2L) (upper), E2-2 injected (middle), and E2-2 and *arl4aa* mRNA co-injected (lower) embryos at 48 hpf.(D) *c*-*myb* expression in control (top), E1 + E2 injected embryos showing absent (second) and reduced (third) *c-myb* expression, and E1 + E2 and *arl4aa* mRNA co-injected (bottom) embryos. Data are shown as means ± SEM. Scale bars, 250 μm (in WISH). The numbers in each WISH showed the numbers of embryos with typical gene expression as shown over the total number of embryos injected in each group.

To address the potential role of *arl4aa* in early HSC specification, we examined the effects of *arl4aa* on somite formation at 12 and 18 hpf, which are sources of Notch signaling required for HSC specification. We demonstrated that *arl4aa* knockout perturbed early somite formation ([Figures S3](#mmc1){ref-type="supplementary-material"}A and S3B). Furthermore, Notch signaling was reduced, as shown by reduced *tp1* expression ([Figures S3](#mmc1){ref-type="supplementary-material"}C--S3E). The observations suggest that *arl4aa* might play a role in Notch signaling and possibly HSC specification during early embryonic development. A potential link between *arl4aa* knockout and Notch signaling perturbation is investigated in subsequent sections.

F0 embryos generated by TALEN E2-2 pair were raised and outcrossed with WT fish to generate F1 embryos. The latter were raised and genotyped by tailfin clipping. F1 fish that carried a 2-bp deletion and 6-bp substitutions, with a frameshift in *arl4aa*, were intercrossed to generate F2 embryos ([Figures 4](#fig4){ref-type="fig"}A and 4B). At 36 hpf, 7 out of 9 (78%) homozygous and 17 out of 27 (63%) heterozygous embryos showed a decrease in *c-myb* expression along the DA. At 48 hpf, 6 out of 8 (75%) homozygous and 11 out of 17 (65%) heterozygous embryos showed reduced *c-myb* expression in CHT ([Figure 4](#fig4){ref-type="fig"}C). *rag1* expression in the thymus was also reduced. Quantification of gene expression was performed by measuring the intensities of *c-myb* expression at 48 hpf and *rag1* expression at 96 hpf in WISH using ImageJ software. Both heterozygous and homozygous mutants showed reduced *c-myb* and *rag1* expression compared with their WT siblings ([Figures 4](#fig4){ref-type="fig"}D and 4E). The number of embryos in each subgroup was limited, as the F1 adult fish showed lower than expected fecundity. However, the observations arising from multiple gene expression and time points collectively supported the proposition that *arl4aa* knockout significantly perturbed definitive hematopoiesis.Figure 4Knockout of Zebrafish *arl4aa* Perturbed Definitive Hematopoiesis in F2 Mutants(A) Strategy of raising F2 mutant embryos.(B) DNA sequencing and genotyping of F2 mutant embryos containing 2-bp deletion and 6-bp substitutions. The amino acids are labeled under the DNA sequence.(C) Expression of *c-myb* in F2 embryos (upper, WT; middle, heterozygous; lower, homozygous) at 36 (left panel) and 48 hpf (middle panel) and of *rag1* at 96 hpf (right panel).(D and E) Intensity of *c-myb* expression in CHT at 48 hpf (D) and *rag1* expression in thymus at 96 hpf (E) as measured by ImageJ software. Data are shown by means ± SEM; n and p values are indicated in (D) and (E). Scale bars, 250 μm (in WISH). The numbers in each WISH showed the numbers of embryos with typical gene expression as shown over the total number of embryos injected in each group.

*arl4aa* Is Required for the Maintenance of the Integrity of the Golgi Complex {#sec2.5}
------------------------------------------------------------------------------

As human ARL4A has been shown to maintain the structural integrity of the Golgi complex, we examined the effects of *arl4aa* knockout on the Golgi complex in VDA, where *arl4aa* was intensely expressed. At 30 hpf, subcellular structures of VDA endothelial cells were examined by transmission electronic microscope (TEM) ([Figure 5](#fig5){ref-type="fig"}Ai-ii). Confirmation of cell types in each section was based on their anatomical location and neighboring structures. Ten sections each from WT and F0 embryos that contained VDA with identifiable Golgi complex were obtained. Knockout of *arl4aa* by the TALEN E2-2 pair resulted in morphologic changes of the Golgi complex in F0 embryos. Compared with WT embryos ([Figure 5](#fig5){ref-type="fig"}Aiii), the Golgi complexes in mutant embryos were elongated and disrupted ([Figure 5](#fig5){ref-type="fig"}Aiv). In others, the Golgi complex was under-developed ([Figure 5](#fig5){ref-type="fig"}Av) and arranged into "onion-skin" configuration ([Figure 5](#fig5){ref-type="fig"}Avi). Electron microscope photographs of all WT and mutant embryos are shown in [Figures S5](#mmc1){ref-type="supplementary-material"}A and S5B. Overall, abnormal Golgi complex morphology was shown in 9 out of 10 mutant cells and in only 1 out of 10 WT cells ([Figures S4](#mmc1){ref-type="supplementary-material"}A--S4C). Importantly, morphology of mitochondria and endoplasmic reticulum (ER) in the VDA were unaffected in mutant embryos ([Figures S5](#mmc1){ref-type="supplementary-material"}A--S5D). Furthermore, the Golgi complexes in the neural tubes of mutant embryos were unaffected ([Figures 5](#fig5){ref-type="fig"}B, [S5](#mmc1){ref-type="supplementary-material"}E, and S5F). These observations suggested that a*rl4aa* functions were specific to the maintenance of the Golgi integrity of the VDA. The integrity of the Golgi complex at the VDA was also evaluated by immunostaining for Golgi membrane protein Giantin. Giantin expression in WT embryos was more localized and condensed in the perinuclear regions, whereas in *arl4aa* MOs Giantin was more dispersed ([Figure 5](#fig5){ref-type="fig"}C). Similar dispersion of Giantin expression was seen in HeLa cells upon *ARL4A* knockdown by two short hairpin RNAs (shRNAs) ([Figures 5](#fig5){ref-type="fig"}D, 5E, [S6](#mmc1){ref-type="supplementary-material"}A, and S6B).Figure 5Deletion of *arl4aa* and *ARL4A* Caused Fragmentation of Golgi Complex in VDA Endothelial Cells in Zebrafish and Human HeLa Cells(A) Electron microscopy of endothelial cells of VDA of un-injected (control \[CON\]) and F0 embryos injected with TALEN E2-2 at 30 hpf. (i--ii) Endothelial cells of VDA are shown in the rectangles. (iii--vi) High power magnification of control (iii) and F0 embryos (iv--vi). Golgi complex shows typical configuration in control embryos (9/10 cells from 4 control embryos) but aberrant morphology in F0 embryos being unusually elongated with disruption (iv, 6/10 cells from 6 embryos), under-developed (v, 1/10 cells from 6 embryos), and "onion-skin" appearance (vi, 2/10 cells from 6 embryos). NC, notochord; VDA, ventral wall of dorsal aorta; PCV, posterior cardinal vein; N, nucleus.(B) Electron microscopy of neural tube in CON (i) and F0 embryos (ii) injected with TALEN E2-2, showing normal Golgi complex configuration (iii and iv). Scale bars, 2 μm (Ai,ii and Bi,ii) and 200 nm (Aiii--vi and Biii, iv). Orange arrowheads: abnormal morphology of the Golgi complex.(C) Immunostaining of Golgi membrane Giantin in control and *arl4aa* morphant (MO) embryos at 30 hpf. The insert on top shows the morphology of 30-hpf embryos with the rectangle highlighting the region of the DA under detailed examination. The dotted red line in the bright field defines the DA. Immunostaining: Giantin was stained with anti-Giantin followed by Alexa Fluor 488-conjugated antibody and the nuclear outline is shown by DAPI staining. The yellow arrowhead denotes the fragmentation of the Golgi complex in endothelial cells from the VDA. The white arrowhead denotes normal expression of Giantin at the Golgi complex. Scale bar, 100 μm.(D) Immunostaining of Giantin followed by Alexa Fluor 594-conjugated antibody in scramble sequence control, *ARL4A* shRNA-1, and *ARL4A* shRNA-2 transfected HeLa cells. GFP+ labeled the successfully transfected cells. White arrowheads indicate normal Golgi complex and yellow arrowheads denote the fragmented and dispersed Giantin staining. Scale bar, 20 μm.(E) Both *ARL4A* shRNA-1 and shRNA-2 significantly increased the proportion of cells with fragmented Golgi complex as shown by Giantin expression, data are shown as means ± SEM (n = 3 experiments, p \< 0.001).See also [Figures S4--S6](#mmc1){ref-type="supplementary-material"}.

*arl4aa* Is Required for the Maturation of Notch Receptor {#sec2.6}
---------------------------------------------------------

Notch signaling plays a pivotal role in the specification of the hemogenic endothelium ([@bib3], [@bib5], [@bib10], [@bib13]). As *arl4aa* was important for maintaining the integrity of the Golgi complex and the latter is crucial for Notch receptor maturation, the mechanistic link between *arl4aa* and Notch signaling was examined. *arl4aa* MO significantly downregulated expression of Notch target genes *hey2*, *her5*, *gata2a*, and *gata2b* but increased that of *notch1* and *notch3* receptors ([Figure 6](#fig6){ref-type="fig"}A). Notch1 protein expression was increased but that of NICD was reduced ([Figure 6](#fig6){ref-type="fig"}B). *arl4aa* MO significantly reduced Notch signaling in VDA at 30 hpf as shown by the decrease in *tp1* + *kdrl* + cells in a double transgenic line *tp1*:GFP; *kdrl*:mcherry ([Figures 6](#fig6){ref-type="fig"}C and 6D). To demonstrate the relationship between *arl4aa* and Notch signaling, *arl4aa* was knocked down in a double transgenic line (*hsp7*0l:gal4; *UAS*:NICD1a-myc) with inducible NICD expression. Heat shock induction of NICD1a expression at the 14--15 somite stage restored *c-myb* + HSC population along the DA in the *arl4aa* morphant at 36 hpf ([Figure 6](#fig6){ref-type="fig"}E).Figure 6Knockdown of *arl4aa* Blocked Cleavage of Notch Receptor Precursor and Downregulated Notch Signaling Pathway along DA Floor(A) Expression of Notch signaling genes in control and *arl4aa* morphant groups at 42 hpf (*notch1*, *notch3*, *hey2*, and *her5*) and 33hpf (*gata2a* and *gata2b*). Data are representative of three independent experiments with error bars representing the mean ± SEM.(B) Western blot showing Notch1 and NICD protein expression in control, *arl4aa* morphant embryos, and DAPT-treated embryos at 42 hpf. The numbers indicate the image intensities of immunoblotting relative to those of tubulin in each embryo group. The intensity in the controls was set arbitrarily as 1. The results are representative of at least three experiments. DAPT, N-\[N-(3,5-difluorophenacetyl)-L-alanyl\]-S-phenylglycine t-butyl ester.(C) Confocal microscope imaging of double transgenic *tp1*:eGFP; *kdrl*:mCherry embryos injected with *arl4aa* MO and examined at 30 hpf. Arrowheads indicate cells in the floor of the DA with active Notch signaling. Scale bar, 100 μm.(D) Enumeration of *tp1* + *kdrl* + HSCs in the floor of DA (n = 8 embryos per group, p \< 0.001). Data are representative of three independent experiments with error bars representing the mean ± SEM.(E) *hsp7*0l:Gal4; *UAS*:NICD1a embryos injected with *arl4aa* MO were heat shocked at 14--15 somites and *c-myb* expression was performed at 36 hpf. Sibling embryos without NICD1a were similarly heat shocked as control. Scale bar, 250 μm. The number of embryos with typical *c-myb* expression as shown over the total number of embryos examined is shown in each panel.

To provide additional evidence of the proposed mechanistic link, we performed immunofluorescence in HeLa cells upon *ARL4A* knockdown, with particular reference to the abundance and subcellular localization of the Golgi complex, NOTCH1, and NICD. shRNAs targeting *ARL4A* resulted in significant reduction in ARL4A protein, attesting to a high knockdown efficiency ([Figure S6](#mmc1){ref-type="supplementary-material"}C). Immunostaining for the Golgi complex was dispersed ([Figures S6](#mmc1){ref-type="supplementary-material"}D and S6E), a finding consistent with our previous observations. Furthermore, there was significant increase in immunostaining for NOTCH1, some of which was located in the peri-nuclear zone ([Figure S6](#mmc1){ref-type="supplementary-material"}D, arrows). There was also a significant decrease in NICD expression ([Figure S6](#mmc1){ref-type="supplementary-material"}E). The observations consolidated our findings in zebrafish and underscored the mechanistic link between ARL4A and maintenance of Golgi complex integrity, where NOTCH receptors are processed ([Figure 7](#fig7){ref-type="fig"}). Furthermore, knockdown and knockout of *arl4aa* induced significant increase in gene expression associated with primitive macrophages ([Figures S7](#mmc1){ref-type="supplementary-material"}A--S7E) but not erythropoiesis or primitive progenitors ([Figure S7](#mmc1){ref-type="supplementary-material"}F). The mechanistic link between Golgi complex integrity and primary macrophage is being investigated.Figure 7Proposed *arl4aa* Function in Zebrafish Definitive HSC Development(A) Notch signaling in normal hemogenic endothelium (HE) cells. Sequential cleavages of Notch receptors occur in the Golgi complex (S1) and cell membranes (S2, S3). NICD is released and translocated to the nucleus where it activates downstream gene expression.(B) Deletion of *arl4aa* disrupted Golgi complex and the first cleavage of Notch precursor, hence production of NICD and subsequent Notch signaling.

Discussion {#sec3}
==========

In this study, we examined the hitherto undescribed expression pattern, functions, and mechanisms of action of *arl4aa* during zebrafish hematopoiesis. Zebrafish *arl4aa* shared sequence similarity with human ARL4 and was expressed preferentially in hematopoietic tissues during embryonic development. Both MO knockdown and TALEN knockout demonstrated the pivotal function of *arl4aa* in the initiation of definitive hematopoiesis. Mechanistically, *arl4aa* was crucial to Notch signaling by maintaining the integrity of the Golgi complex and hence maturation of the Notch receptor. These observations provided important insights to the regulation of embryonic hematopoiesis.

First, to our knowledge this is the first evidence linking *arl4aa*, the Golgi complex, and definitive hematopoiesis. Specifically, the process of EHT was perturbed, as shown by the decrease in the *kdrl* + *cmyb* + HSC population in the VDA of *arl4aa* morphant embryos. The hematopoietic effects of perturbing this hitherto ubiquitous gene function might be related to the localized expression of *arl4aa* at the vicinity of the DA and CHT. Similar expression has been described in a large-scale *in situ* hybridization screening ([@bib27]) and a transcriptome profile of blood and endothelial cells in zebrafish embryos ([@bib4]). Specificity of molecular targeting by *arl4aa* MO was shown by quenching of EGFP of co-injected *arl4aa* 5′ UTR-GFP plasmids. Specificity of hematopoietic phenotypes in *arl4aa* TALEN knockout and MO knockdown embryos could be confirmed by mRNA rescue. Reduction of *arl4aa* expression was also confirmed in F2 heterozygous and homozygous mutants and was probably due to non-sense-mediated mRNA decay ([@bib18]). The observations that *arl4aa* knockdown by MO and knockout by TALEN in both F0 and F2 embryos generated the same hematopoietic phenotype also validated these genetic manipulation approaches. Vasculogenesis was unaffected. These observations underscored the specific and fundamental roles of *arl4aa* in the initiation of EHT. *arl4aa* was also expressed in the posterior blood island (PBI), although it is presently unclear if *arl4aa* is involved in the initiation or maintenance of erythromyeloid progenitors.

Second, the observations provided a mechanistic link between *arl4aa* and Notch signaling. The latter was critically important for HSC specification from hemogenic endothelium. Formation of the aorta was relatively unaffected as shown by *kdrl*:mcherry transgenic embryos and WISH of *efnb2a* expression. Knockdown of *arl4aa* significantly reduced Notch signaling based on reporter transgenic line *tp1*:GFP, western blot for NICD, and qRT-PCR of Notch target genes. Expression of full-length Notch1 precursor was unaffected; supporting the proposition that *arl4aa* interfered with the maturation of Notch receptor and subsequent release of NICD. Intriguingly, *notch1* and *notch3* receptor transcripts were significantly increased. Whether it was mediated by modulation of Notch target genes, of which some were negative regulators of Notch receptor transcription, was unclear ([@bib1]). Drosophila *arf1*, an ortholog of *ARF1*, was shown to play an important role in the maintenance of hematopoiesis by providing a nurturing cellular niche in the lymph gland ([@bib11]). Perturbation of *arf1* resulted in loss of niche cell and differentiation of prohemocytes (HSCs) and aberrant stalling of NICD in the endosomes of crystal cells. Therefore, the findings of this study might support an evolutionarily conserved mechanism whereby members of the ARF and ARL families regulate hematopoiesis and its niche via their effects on Notch signaling. The impact of Golgi complex integrity on Wnt, VEGF, and Hedgehog pathways that are closely associated with Notch signaling and EHT ([@bib10]) will need to be investigated.

Third, this study demonstrated a specific role of the Golgi complex in HSC specification. The Golgi complex receives material from the ER, performs post-translational protein modification, and transfers specific cargoes to various cellular destinations, such as endolysosomes and the plasma membrane ([@bib24], [@bib28]). Perturbation of these processes has been associated with human diseases ranging from neuropsychiatric and musculoskeletal defects to defective erythropoiesis and anemia ([@bib12], [@bib21]). The underlying mechanisms whereby *arl4aa* maintains the integrity of the Golgi complex are unclear. Human ARL4A has been shown to bind GCC185, one of the coiled-coil proteins known as golgins that are involved in the organization of the Golgi complex and intracellular vesicle transport. GCC185 recruits a family of microtubule-binding proteins, known as cytoplasmic linker-associated proteins, to the Golgi complex that together maintain its structure integrity ([@bib17]). In this study, deletion of *arl4aa* disrupted the Golgi complex particularly in the VDA of developing embryos. Their ultrastructural changes were correlated with a consistent KO efficiency and high penetrance of hematopoietic defects in the same clutch of embryos, providing a mechanistic link between *arl4aa* knockout and the morphologic defects of the Golgi complex. Importantly, the morphologies of mitochondria and ER were not affected, suggesting a specific role of *arl4aa* in the maintenance of Golgi complex integrity. Knockdown of human *ARL4A* also resulted in disintegration of the Golgi complex in HeLa cells, as shown by the dispersed immunostaining of Giantin. Our results corroborated with those of a previous study showing that deletion of *ARL4A*, *GCC185*, and its interacting domain, with *ARL4A* caused Golgi disruption ([@bib17]). Compared with the VDA, the PBI was less defined under TEM. Therefore, the role of *arl4aa* in the maintenance of the Golgi complex of the PBI is presently unclear.

Based on the aforementioned observations, we proposed a mechanistic link of *arl4aa*-Golgi complex-Notch definitive hematopoiesis. Perturbed Notch signaling was central to the phenotype induced by defective *arl4aa* function as expression of NICD completely restored definitive hematopoiesis. Although disruption of the Golgi complex might induce widespread effects on cellular protein processing, effects of *arl4aa* on Notch and definitive hematopoiesis were specific, resulting from its unique expression at the VDA where Notch induced initiation of definitive hematopoiesis. Knockdown of methionine aminopeptidase 2 (*metap2*), a cytosolic metalloproteinase that removes NH~2~-terminal methionine from newly synthesized peptides and hence essential for protein maturation, also perturbed initiation of definitive hematopoiesis ([@bib19]). When taken together, these observations might suggest an important role of post-translational protein modification in the modulation of signal transduction during hematopoietic specification.

Experimental Procedures {#sec4}
=======================

Zebrafish Husbandry, Strains, and Treatment {#sec4.1}
-------------------------------------------

Embryos and adult fish were raised under standard laboratory conditions at 28°C (Faculty Zebrafish Core Facility, LKS Faculty of Medicine, HKU) and embryos were staged according to [@bib14]. The study was approved by the Committee of the Use of Laboratory Animals for Teaching and Research at the University of Hong Kong. The transgenic lines *kdrl*:mCherry, *c-myb*:GFP, and *mpeg1*:GFP were generously provided by Dr Yiyue Zhang (Southern Medical University, Guangzhou, China) and *tp1*:GFP, *hsp7*0l:gal4 as well as *UAS*:NICD1a-myc were obtained from Zebrafish International Resources Center (ZIRC). Specifically, heterozygous Tg(*hsp7*0l:gal4) and Tg(*UAS*:NICD1a-myc) embryos were raised to adulthood, genotyped, and crossed to generate both homozygous and double heterozygous embryos. The specific genotyping primers were provided by ZIRC ([Table S1](#mmc1){ref-type="supplementary-material"}). Embryos of double transgenic line (*hsp7*0l:Gal4; *UAS*:NICD1a-myc) were placed in E3 medium and incubated in a 37°C water bath for 45 min at the 14--15 somite stage. Specific genotypes of individual embryos after *c-myb* WISH were also confirmed by PCR.

WISH and Histological Sectioning {#sec4.2}
--------------------------------

WISH was performed as described previously ([@bib19]) using probes for zebrafish *arl4aa*, *c-myb*, *rag1*, *scl*, *pu1*, *l-plastin*, *mpeg1*, *mpo*, *gata1*, *ɑ-hemoglobin*, *efnb2ɑ*, and *flt4* and *myoD*. Probe for *runx1* was a gift from Dr Yiyue Zhang (Southern Medical University, Guangzhou, China). Probe for *myoD* was a gift from Miss Chen Chen (Peking University Shenzhen Graduate School, Shenzhen, China). The embryos were observed using a Nikon SMZ800 stereomicroscope (Nikon Corporation, Kawasaki, Japan) and photographed using a Nikon Digital Sight DS-Fi1 camera (Nikon Corporation, Hong Kong, Hong Kong). To provide objective and quantitative assessments of hematopoiesis in zebrafish embryos, the total area of WISH staining was examined and analyzed by ImageJ software (LOCI, University of Wisconsin, Wisconsin). In brief, by adjusting the detection threshold of images, the software was able to distinguish pixels representing positive signals from those that represented the background. The area of positive staining in individual zebrafish was measured and expressed with reference to a defined area of WISH staining.

For histological sectioning, after WISH embryos were fixed and paraffin embedded. Histological sections (10 μm) were stained with hematoxylin and eosin ([@bib26]). Images were taken using a Nikon Eclipse Ni-U microscope (Nikon Corporation, Tokyo, Japan).

Morpholinos, mRNA Synthesis, and Microinjection {#sec4.3}
-----------------------------------------------

Antisense MO (Gene Tools, Philomath, OR) was designed to target the translation start codon of zebrafish *arl4aa*. A random sequence MO was used as negative control. To test the molecular specificity of MO, 5′ UTR of *arl4aa* gene containing the MO binding sequence was cloned into the BamHI-EcoRI site of the pEGFP-N3 vector (Clontech, Palo Alto, CA) and the plasmid (25 pg) was injected into one-cell-stage embryos with or without MO. To test if mRNA can rescue the hematopoietic defects induced by MO, *arl4aa* complete coding sequence was cloned to pGEMT easy vector (Promega, Madison, WI) and capped mRNA was synthesized using the mMESSAGE mMACHINE SP6/T7 Kit (Ambion, Austin, TX). Silent mutations with 4-bp mismatch were introduced into the MO binding sequence using *arl4aa*-rescue F primer ([Table S1](#mmc1){ref-type="supplementary-material"}) to generate an *arl4aa* mRNA that was resistant to MO. MO (1.0 ng) and mRNA (50 pg) were injected into 1- to 4-cell stage embryos.

Generation of *arl4aa* Zebrafish Mutant {#sec4.4}
---------------------------------------

Three TALEN pairs were designed by parameters described previously ([@bib20]); the targeted binding sequences and the unique restriction enzyme (RE) site within the spacer regions are described in [Table S2](#mmc1){ref-type="supplementary-material"}. The genome loci was amplified using the genotyping primers ([Table S1](#mmc1){ref-type="supplementary-material"}) and sequenced to avoid any polymorphism within the binding and spacer sites. In brief, the length of the TAL binding domain should be 15 repeat variable di-residues (RVDs) with a spacer region of between 14 and 18 bp. T nucleotide upstream of both TAL binding domains resulted in high activity. Golden Gate TALEN and TAL Effector Kit 2.0 were used to assemble TALEN pairs. TALEN RVDs were cloned into a GoldyTALEN scaffold. Then the constructed plasmid was linearized by SacI and purified using a QIAquick PCR Purification Kit (QIAGEN, Valencia, CA). Capped mRNA encoding the TALEN pairs was synthesized using a T3 mMESSAGE mMACHINE Transcription Kit (Ambion), and injected into one-cell-stage embryos (TALEN E2-2 pair 60 pg per arm, TALEN E1 pair 22.5 pg each arm, and TALEN E2 pair 30 pg each arm). Optimum doses were determined by dose-response trials. Typically, the highest dose with less than 50% embryos developing morphological abnormality was chosen. Somatic and germline TALEN-induced mutations were evaluated by PCR and restriction fragment length polymorphisms. For somatic F0 analysis, genomic DNA was extracted from 24 hpf injected embryos and used as template to perform PCR. PCR product was subsequently digested using RE. The efficiency of designed TALENs can be further evaluated by the intensity of bands using ImageJ software. The efficiency of the combination of two TALEN pairs (TALEN E1 + E2) was tested by quantitative PCR targeting *arl4aa* intron using *arl4ab* intron as internal control. Primers used were described in [Table S1](#mmc1){ref-type="supplementary-material"}. The phenotype of somatic mutants was analyzed by WISH followed by genotyping of a single embryo. The F0 embryos generated by the TALEN E2-2 pair were raised to adulthood and outcrossed with WT fish to generate F1 embryos. F1 fish carrying a 2-bp deletion and 6-bp substitutions were intercrossed to generate F2 embryos. Hematopoietic gene expression was shown by WISH and the embryos were classified into homozygous, heterozygous, and WT groups after genotyping.

qRT-PCR {#sec4.5}
-------

Total RNA isolated from trunks of 20--30 zebrafish embryos was reverse transcribed using a SuperScript II Reverse Transcriptase Kit (Life Technologies, Rockvile, MD). Primers to detect transcripts are described in [Table S1](#mmc1){ref-type="supplementary-material"}. Relative gene expression was calculated according to the difference in threshold cycle numbers (Ct) (2^−ΔΔCt^) between control and experimental arms.

Western Blot {#sec4.6}
------------

Protein was harvested by homogenizing 50 embryos (only the trunk region was included) at 42 hpf with 100 μL of CelLytic MT Cell Lysis Reagent (Sigma-Aldrich, St. Louis, MO) supplemented with a protease and phosphatase inhibitor cocktail (1:100, Thermos Scientific, Rockford, IL). WT and morphant embryos as well as embryos treated with 100 μM of N-\[N-(3,5-difluorophenacetyl)-L-alanyl\]-S-phenylglycine t-butyl ester (DAPT) (Sigma-Aldrich) from 24 to 42 hpf were examined. DAPT is a γ-secretase inhibitor that inhibits NICD release from Notch receptor. Protein lysates were centrifuged and boiled for 5 min, separated by electrophoresis on 10% (for anti-NICD incubation) and 6% (for anti-Notch1 incubation) (wt/vol) SDS polyacrylamide gel and electro-transferred to nitrocellulose membranes. The latter were then blocked in 5% milk in Tris-buffered saline with Tween 20 for 1 h, incubated at 4°C overnight with rabbit anti-Notch1 (1:750, 20687-1-AP, Proteintech, Chicago, IL), rabbit anti-Notch1 intracellular domain antibody (anti-NICD, 1:1,000, ab83232, Abcam, Cambridge, MA), or mouse anti-β-actin (1:2,000, A2228, Sigma-Aldrich) antibody diluted in blocking buffer, incubated with secondary horseradish peroxidase (HRP)-linked electrochemiluminescence antibodies (sheep anti-mouse-HRP antibody \[1:3,000, NA931V, Amersham Biosciences, Little Chalfont, UK\], and goat anti-rabbit-HRP antibody \[1:1,000, 32,460, Thermo Fisher Scientific, Rockford, IL\]) for 2 h at room temperature. Proteins were detected using Luminate Forte Western HRP substrate (Millipore, Billerica, MA) and signals were developed using ChemiDoc MP Imaging System (Bio-Rad, Hercules, CA).

Immunofluorescence Staining {#sec4.7}
---------------------------

Embryos were fixed in 4% paraformaldehyde (PFA), permeabilized in cold acetone (10 min), 0.1% trypsin (10 min), and 0.5% hyaluronidase (10 min), blocked in 10% Lamb serum in PBS, and incubated with rabbit anti-Giantin (Abcam, ab24586) at 1:300 at 4°C overnight. The next day, the embryos were incubated in goat anti-rabbit IgG Alexa Fluor 488-conjugated (A11008, Invitrogen, Cambridge, MA) at 1:1,000 dilution and 200 ng/mL DAPI (Life Technologies, Carlsbad, CA) at room temperature for 2 h. Thereafter, the embryos were washed with PBST. Images were acquired with a LSM710 confocal microscope (Carl Zeiss, Carlsbad, CA). Details about human *ARL4A* shRNA construct, transfection in HeLa cell line and immunofluorescence staining were described in [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Confocal Microscopy Imaging {#sec4.8}
---------------------------

Tg(*cmyb*:GFP; *kdrl*:mCherry), Tg(*tp1*:GFP; *kdrl*:mCherry), and Tg(*tp1*:GFP) embryos were imaged by confocal microscopy. Z sections of the DA region were captured by an LSM 710 confocal microscope (Carl Zeiss, MicroImaging, Jena, Germany) and images were generated by maximum projections using a ZEN 2010 D (Carl Zeiss, MicroImaging GmbH, Jena, Germany) software.

TEM {#sec4.9}
---

Embryos at 30 hpf were fixed in 2.5% glutaraldehyde at 4°C overnight and post-fixed in 1% osmium tetroxide for 1 h at room temperature, both in cacodylate buffer (0.1 M \[pH 7.4\]). They were dehydrated in ethanol (50%, 70%, 90%, and 100%), embedded in epoxy resin, sectioned (100 nm) with an ultramicrotome, and stained with 2% aqueous uranyl acetate and Reynold\'s lead citrate. Images were obtained with a Philips CM100 Transmission Electronic Microscope (Philips/FEI, Eindhoven, Holland). The assessor of Golgi morphology was blinded to the genotype of the embryos.

Flow Cytometry and *mpeg1*+ Cell Sorting {#sec4.10}
----------------------------------------

Twenty embryos of *mpeg1*:GFP at 24 hpf were dissociated as described ([@bib19]) and the percentage of GFP+ cells was evaluated by flow cytometry (Cytomics FC 500MPL; Beckman Coulter, Brea, CA).

Statistical Analysis {#sec4.11}
--------------------

Data are shown as mean ± SEM. Comparisons were evaluated by Student\'s t test. p value less than 0.05 was considered statistically significant.
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